Tumors result from the imbalance between cell growth and apoptosis. One of the characteristic changes in cancers is the abnormality in cytoskeleton, which suggests some roles of cytoskeletal proteins in tumorigenesis or the maintenance of tumor cells. Previously we showed that cytoskeletal actin is the substrate of caspases, the proteases responsible for apoptosis, while the role of actin cleavage in apoptosis remained unknown. To examine the cleavage of actin in vivo, we extensively performed immunoblot analysis using actin fragment-speci®c antibody. Here, we showed that, in some solid tumor cells, induction of apoptosis was accompanied by caspase-dependent actin-cleavage to 15 and 31 kDa fragments in vivo. To elucidate the role of actin-cleavage further, we introduced actin cleavedfragments. We found that ectopic expression of an actin 15 kDa fragment induces morphological changes resembling those of apoptotic cells. The expression of the actin fragment induced a dramatic change of cellular actin localization, as visualized by enhanced green¯uorescent protein (EGFP)-tagged actin, while the actin fragment expression did not cause caspase activation nor the cleavage of a marker substrate protein, poly (ADPribose) polymerase. These results indicate that actin cleavage could play a positive role in the morphological changes of apoptosis downstream of caspase activation.
Introduction
Apoptosis is a form of physiological cell death, which plays an important role in various biological processes (Kerr et al., 1972; Wyllie, 1980) . The abnormality in the cell death machinery has been shown to be closely linked with tumorigenesis (Tsujimoto et al., 1985) . The cell death system is well conserved through species; vertebrate cells have recently been shown to have components of the apoptosis execution system (caspase family proteases/apaf-1/bcl-2 family proteins) similar to those of the nematode C. elegans (ced-3/ced-4/ced-9) (Chinnaiyan et al., 1997a,b; Hengartner and Horvitz, 1994; Li et al., 1997; Liu et al., 1996; Yuan et al., 1993; Zou et al., 1997) . In the apoptosis machinery, caspase (interleukin-1b-converting enzyme/ced-3 family) proteases play critical roles in various phases of apoptosis (Alnemri, 1997; Alnemri et al., 1996; Kumar, 1995; Nicholson and Thornberry, 1997; Wong, 1998; Yuan, 1997) . For example, cleavage of nuclear lamins by the proteases could induce apoptotic nuclear condensation (Lazebnik et al., 1995; Neamati et al., 1995; Rao et al., 1996) . Likewise, cleavage of ICAD (inhibitor of caspase-activated DNase)/DFF (DNA fragmentation factor) by caspases leads to the activation of CAD (caspase-activated DNase), an endonuclease responsible for apoptotic DNA fragmentation Liu et al., 1997; Sakahira et al., 1998) . Phosphatidylserine externalization, another characteristic change in apoptosis also depends on caspase activation (Martin et al., 1996; Naito et al., 1997) .
In addition to these nuclear and membrane changes, apoptosis accompanies the dramatic reorganization of the cytoskeleton, which is followed by morphological changes and cellular fragmentation (Brancolini et al., 1995) . The involvement of the micro®lament in morphological changes of apoptosis has been suggested by some inhibitor studies (Cotter et al., 1992) . It has also been reported that several cytoskeletal proteins (such as Gas2, gelsolin, b-catenin, fodrin, actin, PAK-2) are proteolytically cleaved by caspase proteases during apoptosis (Brancolini et al., 1995 (Brancolini et al., , 1997 Cryns et al., 1996; Kayalar et al., 1996; Kothakota et al., 1997; Martin et al., 1995; Mashima et al., 1995a; Rudel and Bokoch, 1997) . However, in some systems, the morphological changes were shown to be independent of the apoptotic proteases (McCarthy et al., 1997; Mills et al., 1998; Toyoshima et al., 1997) . Overall, the mechanisms of morphological changes in apoptosis are still under discussion. We previously showed that cytoskeletal actin is the substrate of caspase proteases (Mashima et al., 1995a,b) , while the signi®cance of actin cleavage in the apoptosis process remained unknown. In this report, we showed that cytoskeletal actin was cleaved in vivo in some solid tumor cells in a caspase-dependent manner. Moreover, we showed that the expression of an actin 15 kDa fragment induced morphological changes as well as the dramatic change in cellular actin localization. Our present results indicate that actin fragmentation by caspases could play a positive role in the morphological changes of apoptosis, especially in some solid tumor cells.
Results

Caspase-dependent cleavage of actin correlates with apoptosis induction
We previously showed that actin is a substrate of caspase proteases while the role of actin cleavage in apoptosis remained unknown. Especially, although actin has been shown to be cleaved by caspases in vitro, there are few evidences for the cleavage of actin in vivo. Therefore, we generated an antibody which is ) for th indicated time, and the development of apoptosis (cells % in pre-G1 population) was analysed using a¯ow cytometer as described in Materials and methods. (C) HeLa or A431 cells were left untreated or treated with 40 mg/ml of etiposide for 36 h and caspase protease activity in the cell extracts was measured using DEVD-MCA, as described in Materials and methods speci®c to 15 kDa actin cleaved-fragment and extensively tested whether actin could be cleaved during apoptosis in the cells. When HeLa or A431 cells were treated with 40 mg/ml etoposide, the cells died with the typical feature of apoptosis. As shown in Figure 1A , the apoptotic cell-membrane blebbing was observed in the drug-treated cells, and the apoptotic cells increased in a time-dependent manner ( Figure 1B) . The apoptosis induction of these cell lines accompanied the marked activation of caspase protease ( Figure 1C ) and, correspondingly, the induction of apoptosis was eciently prevented by the caspase inhibitor Z-D-DCB (benzyloxycarbonylAsp-CH 2 OCO-2,6-dichlorobenzene) but not by the nonspeci®c compound Z-D-OH (benzyloxycarbonylaspartic acid) ( Figure 1B ). These results indicated that apoptosis induction in these cell lines is dependent on caspases. To test whether cytoskeletal actin is cleaved during apoptosis, we performed immunoblot analysis using anti-GQVIT (Gly-GlnVal-Ile-Thr), an antibody speci®c to the 15 kDa fragment of actin . In the apoptotic HeLa and A431 cell lysates, we detected the expression of 15 kDa actin fragment. Immunoblot analysis using C4 antibody revealed that cellular actin was partially cleaved to 15 kDa and 31 kDa fragments after treatment with etoposide ( Figure 2 ), while the expression of gelsolin, another substrate protein of caspases, was basally low and its cleaved fragments were not detected even in the drug-treated cells (data not shown). Furthermore, the cleavage of actin as well as the morphological changes of apoptosis were eciently inhibited by Z-D-DCB. As a negative control, Z-D-OH, which does not inhibit caspases, did not inhibit the processes. Similar results were obtained when human embryonic kidney 293T cells were induced to undergo apoptosis by the treatment with staurosporine (data not shown).
From these results, we concluded that actin is at least partially cleaved by caspases in vivo in accordance with apoptosis development in multiple cell lines.
Expression of the actin fragment induces morphological changes resembling apoptosis
In order to clarify the role of actin-cleavage in apoptosis, we examined the eect of actin fragment expression in viable cells. First, we transiently transfected HeLa or A431 cells with HA-tagged 15 kDa or 31 kDa actin fragment expression constructs as well as that of HA-tagged full-length actin. The transfection eciency, however, was not high enough to examine the eect in these cell lines. Next, we expressed these plasmid constructs to 293T cells, since caspase-mediated cleavage of actin was also observed in staurosporine-induced apoptosis of the cells. Actin or its cleaved fragments were transiently expressed in 293T cells, as detected by anti-HA antibody ( Figure 3A ). We further con®rmed the expression levels of those actin fragments by using anti-actin monoclonal antibody C4, which is directed to full-length actin (45 kDa) and the 31 kDa fragment. The expressions of exogenously expressed actin or its fragments were &5% as compared with that of endogenous actin (The transfection eciency was &23% in these experiments), while &7% of endogenous actin was cleaved in HeLa cells after 36 h treatment with etoposide ( Figure 2 ). (At this time point, &20% of the cells were induced to undergo apoptosis ( Figure 1B) . Thus, the expression levels of exogenously expressed actin fragments correspond to those of caspase-cleaved actin fragments in apoptotic HeLa cells. To examine the eect of these actin fragments on the cells, we transiently transfected the actin-fragments expression vectors with the expression vector for enhanced green¯uorescent protein (EGFP). As shown in Figure 3B , we observed the induction of a shrunken morphology in 15 kDa fragment transfected EGFP-positive cells. This change was rather speci®c in 15 kDa-expressed cells (and in 31 kDa-expressed cells to a lesser extent), while no such change was clearly observed in mock or full-length HA-tagged actintransfected cells. Forty-eight hours after transfection of mock, 15 kDa, 31 kDa and 45 kDa fragments, the percentages of cells with the shrunken morphology in EGFP-positive cells were 9.9%, 43.1%, 20.2% and 12.9%, respectively ( Figure 3C ). These results directly indicated that a 15 kDa actin fragment could speci®cally induce morphological changes that resemble those of apoptosis.
Exogenously expressed actin fragment does not activate intracellular caspase proteases
As shown, during apoptosis development, the induction of morphological changes and cleavage of actin was a downstream event of caspase activation ( Figure  2 ). To clarify whether the morphological changes induced by the actin fragment could depend on caspases, we examined the activation of caspases in the actin fragment-expressed cells. Figure 4A shows that caspase activity was not activated in the actin fragment-expressed cells, while, as a positive control, this activity was signi®cantly elevated in staurosporinetreated 293T cells. Consistently, the caspase-3 pre- cursor (p32) was not processed to its active-form in either actin fragment-expressed cells ( Figure 4B ), and the cleavage of a substrate protein, poly (ADP-ribose) polymerase (PARP), was not observed in the cells ( Figure 4C ). These results indicate that the induction of cell shrinkage in the actin fragment-expressed cells was independent of caspase protease activation.
An exogenously expressed actin fragment causes dramatical changes in cellular actin localization
As reported previously, actin polymerization in vitro was prevented by caspase-mediated actin cleavage (Kayalar et al., 1996) . To examine the eect of actin fragments on the cellular actin localization in vivo, we next transfected actin fragment expression plasmids with a EGFP-tagged actin expression construct ( Figure  5A ), since green¯uorescent protein (GFP)-tagged actin has been recently reported to be a useful indicator of actin localization in viable cells (Westphal et al., 1997) .
As shown in Figure 5B , while cellular actin in mock, 31 kDa and 45 kDa expressed cells seemed normally localized in cytoplasm, the actin network in the 15 kDa expressed cells was markedly condensed and partially fragmented. These results suggested that 15 kDa actin fragment could aect the cellular micro®lament structure in vivo.
Discussion
Apoptotic cell death, as a genetically controlled program, accompanies dramatic morphologic shrinkage and cellular fragmentation to small apoptotic bodies. These cellular changes, as well as phosphatidylserine externalization (Shiratsuchi et al., 1997) , could be an important step required for phagocytosis of death cells. The mechanisms of these changes are still unclear.
We have shown that cytoskeletal actin is a potential target of caspase proteases, which are activated during apoptosis. In this study, we showed that, in some solid tumor cells, actin was partially cleaved to 15 kDa and 31 kDa fragments by activated caspases during the development of apoptosis. The inhibition of caspases by the selective inhibitors Z-D-DCB or Z-VAD-FMK did not only prevent actin cleavage in vivo but also the morphologic changes of apoptosis. Moreover, ectopic expression of actin 15 kDa fragment induced morphologic shrinkage resembled that of apoptotic cells. These results indicated that caspase-dependent actin cleavage could contribute, at least in part, to the apoptotic morphologic changes. As shown above, not all cellular actin was cleaved during apoptosis. However, our data show that the cleavage of a part of cellular actin could be enough to aect cell morphology, since the expression level of 15 kDa fragment was relatively low in transfected cells as compared by that of endogenous actin (data not shown) but was, nevertheless, enough to induce morphologic shrinkage. To clarify the precise role of actin-cleavage further, it should be needed to establish a cell system in which endogenous actin is replaced with a cleavage site mutant, although this could be a dicult experiment.
Previously, it was reported that actin fragments cleaved by caspase-1/interleukin-1b-converting enzyme (ICE) could not polymerize eectively in vitro (Kayalar et al., 1996) , suggesting that the fragments could aect actin ®lament network formation. In view of this, we examined the eect of actin fragment expression on cellular actin localization. We found that actin localization was markedly changed in 15 kDa-expressed cells. This observation suggested that the actin 15 kDa fragment could induce morphologic changes by aecting actin cytoskeleton. In apoptotic cells, activated caspases cleave actin to 15 kDa and 31 kDa fragments. Furthermore, the ectopically expressed 15 kDa actin fragment induced morphologic change without activating caspase protease(s). Taken together, these results indicated that actin fragment-mediated cellular shrinkage is an event downstream of caspase activation.
Although the 15 kDa actin fragment induced cellular shrinkage, formation of apoptotic bodies was not clearly observed in the transfected cells. These results suggested that actin-cleavage by caspases was not enough to induce the apoptotic cellular fragmentation process. It has been shown that fodrin, Gas2, b-catenin or PAK-2, another micro®lament-related proteins, are Figure 4 Caspase activations was not induced by the expression of actin fragments. 293T cells (2610 6 cells) were transiently transfected with 5 mg pcDNA3-HA+1.5 mg pcDNA3-EGFP (M,M+VP), with 5 mg pcDNA3-15K-HA+1.5 mg pcDNA3-EGFP (15K), with 5 mg pcDNA3-31K-HA+1.5 mg pcDNA3-EGFP (31K), with 5 mg pcDNA3-actin-HA+1.5 mg pcDNA3-EGFP (45K). Forty-eight hours after transfection, cells were left untreated (M, 15K, 31K, 45K) or treated with 10 mM staurosporine (M+STS) for 24 h. The cell extracts were prepared, and the caspase protease activity in the cell extracts (A), processing of caspase-3 precursor (B) and cleavage of PARP (C) were examined, as described in Materials and methods also cleaved by caspase proteases in apoptotic cells, suggesting that apoptotic morphologic changes and cellular fragmentation could proceed from the caspasemediated cleavage cascade of these proteins. Recently, caspase-3-mediated cleavage of gelsolin was reported to be involved in apoptotic morphologic changes (Kothakota et al., 1997) . However, we could not detect high levels of gelsolin expression in HeLa or A431 cells, and the gelsolin cleavage did not correlate with induction of apoptosis (data not shown). In tumor cells, loss of gelsolin expression frequently occurs (Asch et al., 1996; Chaponnier and Gabbiani, 1989; Tanaka et al., 1995) ; therefore, gelsolin-cleavage could not be involved in induction of apoptosis in our tumor cell lines. These results indicate that the apoptotic morphologic changes could be dierentially regulated in each cell type.
We have shown herein that the actin fragment cleaved by caspases induced apoptosis-like morphologic changes by aecting the actin cytoskeleton. These ®ndings could explain part of the mechanism of apoptosis development. From a clinical point of view, some strategies such as gene transfer of cDNA encoding the 15 kDa fragment of actin may serve as another therapeutic approach for killing tumor cells, since the fragment has the potency to induce apoptosislike cell shrinkage. As reported previously, a point mutation around the caspase-cleavage site in the actin gene was shown to be associated with transformation of cells (Vandekerckhove et al., 1980) . The relationship of the loss in apoptosis potency with tumorigenesis should be studied further.
Materials and methods
Cell lines and cell culture
Human epitheloid carcinoma cells (HeLa), human epidermoid carcinoma cells (A431) and human embryonic kidney cells (293T) were grown in DME medium (Nissui Co. Ltd, Tokyo, Japan), supplemented with 10% heat-inactivated fetal bovine serum and 100 mg/ml of kanamycin in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Chemicals and proteins
Etoposide was kindly provided by Bristol Meyers-Squibb (Tokyo, Japan). Staurosporine was a kind gift from Kyowahakkou Co, Ltd. (Tokyo, Japan). Z-D-DCB was synthesized as described previously (Dolle et al., 1994) or purchased from Funakoshi (Tokyo, Japan). Z-D-OH was obtained from Advanced Chemtech (Louisville, KY, USA). Z-VAD-FMK was purchased from Bachem (Bubendorf, Switzerland). Anti-human gelsolin antibody was from Sigma Chemical Co. (St Louis, MO, USA). Anti-human caspase-3 monoclonal antibody was obtained from Transduction Laboratories (Lexington, KY, USA). Antiactin monoclonal antibody (C4) was from Cosmo Bio Co, Ltd. (Tokyo, Japan). Anti-HA monoclonal antibody was purchased from Boehringer Mannheim (Tokyo, Japan). Ā uorogenic substrate for caspase protease, DEVD-MCA, was obtained from the Peptide Institute (Osaka, Japan). Anti-EGFP antibody was from Clontech (Palo Alto, CA, USA). Anti-GQVIT polyclonal antibody was prepared as described previously . Anti-poly (ADP-ribose) polymerase (PARP) antibody was from Pharmingen (San Diego, CA, USA).
Western blot analysis
The Western blot analysis using anti-caspase-3, anti-actin (C4) and anti-GQVIT was performed as described previously . For the preparation of cell lysate, we directly added SDS-sample buer to the cells in order to avoid the actin-cleavage by caspases in vitro. Western blot analysis using anti-gelsolin, anti-EGFP, anti-HA and anti-PARP was performed as described below. Cell lysates were separated by 15/25% gradient polyacrylamide gel (for anti-EGFP and anti-HA) or by 4/20% (7) or with 5 mg pcDNA3-EGFP-tagged actin (EGFP-actin). Forty-eight hours after transfection, cell extracts were prepared, and the expression of EGFP-actin was examined by Western blot analysis using anti-EGFP antibody, as described in Materials and methods. (B) 293T cells (2610 6 cells) were transiently transfected with 5 mg pcDNA3-HA+1.5 mg pcDNA3-EGFP-tagged actin (Mock), with 5 mg pcDNA3-15K-HA+1.5 mg pcDNA3-EGFP-tagged actin (15K), with 5 mg pcDNA3-31K-HA+1.5 mg pcDNA3-EGFP-tagged actin (31K), or with 5 mg pcDNA3-actin-HA+1.5 mg pcDNA3-EGFP-tagged actin (45K). Forty-eight hours after transfection, the change in cellular actin localization, as detected by the expressed EGFP-actin, was analysed using¯uorescence microscopy gradient polyacrylamide gel (for anti-gelsolin and anti-PARP), and the electrophoresed proteins in the polyacrylamide gels were transblotted onto a nitrocellulose membrane. After blocking at room temperature for 1 h in blocking buer (PBS(7) ± 10% skim milk ± 0.1% Tween 20), the membrane was soaked at room temperature for 2 h in anti-gelsolin antibody (1 : 200 dilution), in anti-EGFP antibody (1 : 250 dilution), in anti-HA antibody (1 : 200 dilution) or in anti-PARP antibody (1 : 500 dilution) followed by three washes in PBS(7) ± 0.1% Tween 20 and incubation in anti-mouse Ig-peroxidase conjugated at room temperature for 1 h. After several washes, the bands were visualized by ECL.
Flow cytometry analysis
The quanti®cation of apoptotic HeLa and A431 cells was performed using¯ow cytometry, as described previously (Chen et al., 1996) . In brief, after the drug treatment, cells were harvested and ®xed in 70% ethanol. Following treatment with RNase A (1 mg/ml in 0.1 M phosphate buer, pH 7.0), cells were stained with propidium iodide (PI) solution (50 mg/ml in 0.1% sodium citrate, 0.1% Nonidet P-40). Cells were analysed and the percentages of pre-G1 cells were counted using a Becton Dickinson FACScan¯ow cytometer (Braintree, MA, USA).
Protease assays with¯uorogenic peptide substrate
Cell lysates were prepared as described previously (Chen et al., 1996) . Cell lysates (10 mg of protein for each sample) were incubated with 1 mM DEVD-MCA at 378C for 1 h and the release of 7-amino-4-methylcoumarin was monitored using a spectro¯uorometer (Hitachi F-2000) at an excitation wavelength of 380 nm and an emission wavelength of 460 nm.
Plasmid vector construction
Construction of enhanced green¯uorescent protein (EGFP) and EGFP-tagged actin expression vectors EGFP cDNA was ampli®ed by PCR using a pEGFP vector DNA (Clontech, Palo Alto, CA, USA) as a template. The sense and antisense primers for this process were 5'-ACAGCTATGACCATGATTACGCC-3' and 5'-TTTCT-CGAGCTTGTACAGCTCGTCCATGCC-3', respectively. The PCR-ampli®ed EGFP cDNA fragment was digested by and cloned into the BamHI ± XhoI site of pcDNA3 to generate pcDNA3-EGFP. For the construction of the EGFP-tagged actin plasmid, actin cDNA was ampli®ed by PCR using cDNA of U937 cells as a template. The sense and antisense primers for this process were 5'-TTTCTCGAGACCATGGATGATGATATCGCCGC-3' and 5'-TTTTCTAGACATAGTCCGCCTAGAAGCATT-TGC-3', respectively. The PCR-ampli®ed actin cDNA fragment was digested and cloned into the XhoI ± XbaI site of pcDNA3 ± EGFP to generate pcDNA3 ± EGFPtagged actin.
Construction of actin-fragment expression vectors
To obtain the human b-actin cDNA and its partial fragments, PCR was performed using pcDNA3 ± EGFP-tagged actin as a template. The sense and antisense primers for full-length actin cDNA were: 5'-TTTGGATCCACCATG-GATGATGATATCGCCGC-3' and 5'-TTTGAA-TTCCA-GAAGCATTTGCGGTGGACGATGG-3', respectively. The sense and antisense primers for the 15 kDa actin fragment cDNA were: 5'-TTTGGATCCATGGGC-CAGGTCATCACCATTGGCAAT-3' and 5'-TTTGAA-TTCCAGAAGCATTTGCGGTGGACGATGG-3', respectively. The sense and antisense primers for 31 kDa actin fragment cDNA were: 5'-TTTGGATCCACCATGGAT-GATGATATCGCCGC-3' and 5'-TTTGAATTCCCGT-CAGGCAGCTCGTAGCTCTTC-3', respectively. The speci®c fragments obtained from the PCR were digested, fused with a cDNA encoding an HA epitope, YPYDVP-DYASLG, at the 3' end and cloned into the EcoRI ± BamHI site of pcDNA3 to generate pcDNA3-actin-HA, pcDNA3-15K-HA and pcDNA3-31K-HA. They were further con®rmed by sequencing both strands using a Sequenase reaction kit (Amersham, Cleveland, OH, USA).
Transient transfections
293T cells were seeded at a density of 2610 6 cells/10 ml in 10 cm dishes. Twenty-four hours later, the cells were transfected by calcium phosphate precipitation with 1.5 mg EGFP (or EGFP-actin) expression plasmids and 5 mg actin fragment expression plasmids. The morphological changes of the cells were observed using a light microscopy or a¯uorescence microscopy (UFX-II A; Nikon, Tokyo, Japan).
